Skip to main content
. 2019 May 23;63(6):e02264-18. doi: 10.1128/AAC.02264-18

FIG 3.

FIG 3

In vitro interaction of allopurinol with nitroheterocyclic compounds. (A) Fifty percent fractional inhibitory concentration (FIC50) of each drug in combination and ∑FIC50 of allopurinol plus benznidazole and allopurinol plus nifurtimox. (B) Graphical representations of the interaction between allopurinol and benznidazole. (C) Graphical representations of the interaction between allopurinol and nifurtimox.